3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
NIH
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
43
Breast
16
Genitourinary
13
Other hematologic neoplasm
12
Lymphoid
12
CNS
12
Plasma cell
11
Myeloid
11
Dermatologic
10
Sarcoma
3
Gastrointestinal
3
Thoracic
2
Other solid neoplasm
1
Other
1
NET
1
Head & Neck
1
Endocrine
1
Conditions
Head and Neck Neoplasms
1869
Squamous Cell Carcinoma of Head and Neck
1109
Nasopharyngeal Carcinoma
535
Thyroid Neoplasms
518
Mouth Neoplasms
347
Oropharyngeal Neoplasms
292
Laryngeal Neoplasms
197
Neoplasms
187
Carcinoma, Squamous Cell
187
Breast Neoplasms
183
Lung Neoplasms
181
Nasopharyngeal Neoplasms
160
Thyroid Nodule
154
Salivary Gland Neoplasms
135
Thyroid Cancer, Papillary
122
Neoplasm Metastasis
113
Carcinoma, Non-Small-Cell Lung
112
Hypopharyngeal Neoplasms
111
Melanoma
105
Prostatic Neoplasms
99
Esophageal Neoplasms
95
Colorectal Neoplasms
90
Thyroid Diseases
86
Uterine Cervical Neoplasms
82
Recurrence
81
Pancreatic Neoplasms
79
Ovarian Neoplasms
70
Sarcoma
68
Stomach Neoplasms
65
Xerostomia
62
Interventions
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gestational Trophoblastic Disease
×
Head & Neck
×
Clear all
NCT06790706
2025-10-06
IMMUNORARE5
Hospices Civils de Lyon
Phase 2
Recruiting
154 enrolled